NASDAQ:NVDQ - Novadaq Technologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $11.75 0.00 (0.00 %) (As of 09/11/2017)Previous Close$11.75Today's Range$11.75 - $11.7552-Week Range$5.84 - $12.74VolumeN/AAverage Volume797,205 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases. Receive NVDQ News and Ratings via Email Sign-up to receive the latest news and ratings for NVDQ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:NVDQ Previous Symbol CUSIPN/A CIK1173293 Webnovadaq.com Phone+1-905-6293822Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Novadaq Technologies (NASDAQ:NVDQ) Frequently Asked Questions What is Novadaq Technologies' stock symbol? Novadaq Technologies trades on the NASDAQ under the ticker symbol "NVDQ." How were Novadaq Technologies' earnings last quarter? Novadaq Technologies Inc. (NASDAQ:NVDQ) issued its earnings results on Wednesday, May, 3rd. The medical research company reported ($0.24) EPS for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.03. The medical research company had revenue of $21.08 million for the quarter, compared to analyst estimates of $20.12 million. View Novadaq Technologies' Earnings History. Has Novadaq Technologies been receiving favorable news coverage? Press coverage about NVDQ stock has been trending positive on Monday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Novadaq Technologies earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. What other stocks do shareholders of Novadaq Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novadaq Technologies investors own include Hawkins (HWKN), CA (CA), BlackRock (BLK), Endologix (ELGX), Genocea Biosciences (GNCA), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), DH (DH), Micron Technology (MU) and Rio Tinto (RIO). Who are Novadaq Technologies' key executives? Novadaq Technologies' management team includes the folowing people: William A. MacKinnon, Chairman of the BoardRick Mangat Ph.D., President, Chief Executive Officer, Bio & Compensation - Roger Deck, Chief Financial Officer, Bio & Compensation - Lori Swalm, Vice President of Marketing, Bio & Compensation - Derrick Guo, General Counsel, Corporate Secretary, Bio & Compensation - Anthony F. Griffiths, Lead Independent DirectorLisa N. Colleran, DirectorKaren A. Licitra, Director, Bio & Compensation - Patrice E. Merrin, Independent DirectorThomas G. Wellner, Independent Director How do I buy shares of Novadaq Technologies? Shares of NVDQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Novadaq Technologies' stock price today? One share of NVDQ stock can currently be purchased for approximately $11.75. What is Novadaq Technologies' official website? The official website for Novadaq Technologies is http://novadaq.com. How can I contact Novadaq Technologies? Novadaq Technologies' mailing address is 5090 Explorer Dr Suite 202, MISSISSAUGA, ON L4W 4T9, Canada. The medical research company can be reached via phone at +1-905-6293822. MarketBeat Community Rating for Novadaq Technologies (NASDAQ NVDQ)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 307 (Vote Outperform)Underperform Votes: 210 (Vote Underperform)Total Votes: 517MarketBeat's community ratings are surveys of what our community members think about Novadaq Technologies and other stocks. Vote "Outperform" if you believe NVDQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVDQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: Why does a company issue an IPO?